Tactile Systems Technology Analysts Raise Their Forecasts After Better-Than-Expected Q4 Earnings

Tactile Systems Technology, Inc. (NASDAQ:TCMD) on Tuesday posted upbeat fourth-quarter earnings and also announced the acquisition of LymphaTech.

Tactile Systems reported fourth-quarter earnings of 46 cents, better than the consensus of 44 cents. Sales jumped 21% to $103.59 million, beating the Wall Street estimates of $93.80 million, attributable to lymphedema and airway clearance product lines.

Tactile Systems forecasts fiscal 2026 sales between $357 million-$365 million compared to the consensus of $347.94 million. The company expects adjusted EBITDA in the range of $49 million to $51 million.

“In 2025, we executed with discipline against our core growth strategies, delivering double-digit revenue growth, expanding gross margin and adjusted EBITDA, and generating strong cash flow, while continuing ...

Full story available on Benzinga.com